Clinical Trials in Phoenix

Showing 5941-5960 of 16,646 trials

Ambispective Clinical Evaluation of Sophono™

NCT03143257

Study to accumulate post-market clinical evidence for the safety and effectiveness of the Sophono Alpha 2 and Alpha 2 Maximum Power Output (MPO) systems in subjects diagnosed with conductive hearing loss, single-sided deafness and mixed hearing loss who currently have or have had the Sophono implant.

Conductive Hearing LossSingle-Sided DeafnessMixed Hearing Loss

Medtronic Surgical Technologies71 participantsStarted Jun 2017

Phoenix, Arizona, United States • Gainesville, Florida, United States • Jacksonville, Florida, United States +3 more locations

COMPLETED11 miles

TARGET Post-Approval Study

NCT02800863

The purpose of this prospective, multicenter, single arm post-approval study is to demonstrate continued safety of the Axium and Proclaim Neurostimulator System for dorsal root ganglion (DRG) stimulation. The primary endpoint is the 12-month serious adverse event rate for permanent implants.

Complex Regional Pain Syndrome (CRPS)

Abbott Medical Devices426 participantsStarted Aug 2016

Scottsdale, Arizona, United States • Camarillo, California, United States • Larkspur, California, United States +41 more locations

Ambispective Clinical Evaluation of Sophono™

TARGET Post-Approval Study

Find Trials by Condition in Phoenix

Safety and Efficacy of Piromelatine in Mild Alzheimer's Disease Patients (ReCOGNITION)

A Clinical Safety Study of AT-100 (rhSP-D) in Preterm Neonates at High Risk for Bronchopulmonary Dysplasia (BPD)

An Investigational Study of Experimental Medication BMS-986165 in Participants With Moderate to Severe Crohn's Disease

Long Term Comparative Effectiveness of Once Weekly Semaglutide Versus Standard of Care in a Real World Adult US Population With Type 2 Diabetes - a Randomized Pragmatic Trial

Immunogenicity and Safety Study of GSK's MenABCWY Vaccine in Healthy Adolescents and Adults Previously Primed With MenACWY Vaccine

A Study of XmAb®23104 in Subjects With Selected Advanced Solid Tumors (DUET-3)

Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity

The DES BTK Vascular Stent System vs PTA in Subjects With Critical Limb Ischemia

A Study of Vibegron in Pediatric Participants 2 Years to Less Than (<) 18 Years of Age With NDO and on CIC

A Study of Ixazomib+Daratumumab+Dexamethasone (IDd) in Relapsed and/or Refractory Multiple Myeloma (RRMM)

Testing the Addition of an Anti-cancer Drug, Berzosertib (M6620, VX-970), to the Usual Treatments (Carboplatin and Gemcitabine) and to Pembrolizumab for Patients With Advanced Squamous Cell Non-small Cell Lung Cancer

A Study of Atezolizumab With or Without Bevacizumab in Combination With Cisplatin Plus Gemcitabine in Patients With Untreated, Advanced Biliary Tract Cancer

Mass Accumulation Rate (MAR) as a Predictive Biomarker in Multiple Myeloma

Selective Estrogen Receptor Modulators to Enhance the Efficacy of Viral Reactivation With Histone Deacetylase Inhibitors

Training in Exercise Activities and Motion for Growth (TEAM 4 Growth) RCT

A Study to Evaluate Safety and Efficacy of AMB-05X Injections in Subjects With TGCT

Trial of Andexanet Alfa in ICrH Patients Receiving an Oral FXa Inhibitor

Evaluate the Efficacy and Safety of TGR-1202 in Participants With Chronic Lymphocytic Leukemia Who Are Intolerant to Prior Therapy